221 related articles for article (PubMed ID: 8800511)
21. AIDS and hemophilia: experience in the La Paz Hemophilia Center.
Magallón Martínez M; Ortega F; Pinilla J
Haemostasis; 1992; 22(5):281-92. PubMed ID: 1362177
[TBL] [Abstract][Full Text] [Related]
22. Viral pathogens.
Ragni MV; Sherman KE; Jordan JA
Haemophilia; 2010 Jul; 16 Suppl 5():40-6. PubMed ID: 20590855
[TBL] [Abstract][Full Text] [Related]
23. The significance of the blood-borne viruses: blood banking and transfusion medicine.
Sherwood WC
Dev Biol Stand; 1993; 81():25-33. PubMed ID: 8174810
[TBL] [Abstract][Full Text] [Related]
24. Patterns of hepatitis G viraemia and liver disease in haemophiliacs previously exposed to non-virus inactivated coagulation factor concentrates.
Hanley JP; Jarvis LM; Hayes PC; Lee AJ; Simmonds P; Ludlam CA
Thromb Haemost; 1998 Feb; 79(2):291-5. PubMed ID: 9493578
[TBL] [Abstract][Full Text] [Related]
25. [GBV-C/HGV and TTV infection markers in Polish blood donors and haemophilia patients].
Grabarczyk P; Brojer E; Windyga J; łopaciuk S; Klukowska A; Mikulska M
Przegl Epidemiol; 2006; 60(3):581-8. PubMed ID: 17249183
[TBL] [Abstract][Full Text] [Related]
26. High prevalence of GB virus C/hepatitis G virus infection among homosexual men infected with human immunodeficiency virus type 1: evidence for sexual transmission.
Nerurkar VR; Chua PK; Hoffmann PR; Dashwood WM; Shikuma CM; Yanagihara R
J Med Virol; 1998 Oct; 56(2):123-7. PubMed ID: 9746067
[TBL] [Abstract][Full Text] [Related]
27. Correlation of hepatitis B virus, hepatitis D virus and human immunodeficiency virus type I infection markers in hepatitis B surface antigen positive haemophiliacs and patients without haemophilia with clinical and histopathological outcome of hepatitis.
Wagner N; Rotthauwe HW; Becker M; Dienes HP; Mertens T; Födisch HJ; Brackmann HH
Eur J Pediatr; 1992 Feb; 151(2):90-4. PubMed ID: 1537369
[TBL] [Abstract][Full Text] [Related]
28. Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation.
Darby SC; Ewart DW; Giangrande PL; Spooner RJ; Rizza CR; Dusheiko GM; Lee CA; Ludlam CA; Preston FE
Lancet; 1997 Nov; 350(9089):1425-31. PubMed ID: 9371165
[TBL] [Abstract][Full Text] [Related]
29. Comparison of GB virus C, HIV, and HCV infection markers in hemophiliacs exposed to non-inactivated or inactivated factor concentrates.
Kupfer B; Ruf T; Matz B; Nattermann J; Spengler U; Rockstroh JK; Brackmann HH; Blümel J; Tacke M; Kaiser R
J Clin Virol; 2005 Sep; 34(1):42-7. PubMed ID: 16087123
[TBL] [Abstract][Full Text] [Related]
30. [Viral risks associated with blood transfusion].
Barin F
Rev Fr Transfus Hemobiol; 1993 Jan; 36(1):73-81. PubMed ID: 8386512
[TBL] [Abstract][Full Text] [Related]
31. Sexual transmission of GB virus C/hepatitis G virus.
Scallan MF; Clutterbuck D; Jarvis LM; Scott GR; Simmonds P
J Med Virol; 1998 Jul; 55(3):203-8. PubMed ID: 9624607
[TBL] [Abstract][Full Text] [Related]
32. Clinical evaluation of viral safety of coagulation factor VIII and IX concentrates.
Mannucci PM
Vox Sang; 1993; 64(4):197-203. PubMed ID: 8517048
[TBL] [Abstract][Full Text] [Related]
33. Infection with hepatitis GB virus among Japanese hemophiliacs.
Nishiyama Y; Nakashima H; Hino K; Mori K; Ishikawa M; Okamoto H
Transfusion; 1996 Jul; 36(7):669. PubMed ID: 8701464
[No Abstract] [Full Text] [Related]
34. Safety surveillance in haemophilia and allied disorders.
Lassila R; Makris M
J Intern Med; 2016 Jun; 279(6):515-23. PubMed ID: 27001233
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and genotypes of GB virus C/hepatitis G virus (GBV-C/HGV) and hepatitis C virus among patients infected with human immunodeficiency virus: evidence of GBV-C/HGV sexual transmission.
Ibáñez A; Giménez-Barcons M; Tajahuerce A; Tural C; Sirera G; Clotet B; Sánchez-Tapias JM; Rodés J; Martínez MA; Saiz JC
J Med Virol; 1998 Aug; 55(4):293-9. PubMed ID: 9661838
[TBL] [Abstract][Full Text] [Related]
36. Life time expectancy of hemophilia patients infected with HIV-1 with the risk of hepatocellular carcinoma after HCV infection.
Tatsunami S; Mimaya J; Nakamura I; Yago N; Meguro T; Yamada K
Medinfo; 1995; 8 Pt 2():912. PubMed ID: 8591584
[TBL] [Abstract][Full Text] [Related]
37. [Virus in hemophilia: current status and future perspectives].
Aguilar C; Félix Lucía J
Sangre (Barc); 1996 Apr; 41(2):141-5. PubMed ID: 9045355
[No Abstract] [Full Text] [Related]
38. Seroprevalence of parvovirus B19, cytomegalovirus, hepatitis A virus and hepatitis E virus antibodies in haemophiliacs treated exclusively with clotting-factor concentrates considered safe against human immunodeficiency and hepatitis C viruses.
Flores G; Juárez JC; Montoro JB; Tusell JM; Altisent C; Juste C; Jardí R
Haemophilia; 1995 Apr; 1(2):115-7. PubMed ID: 27214319
[TBL] [Abstract][Full Text] [Related]
39. Legal, financial, and public health consequences of transfusion-transmitted hepatitis C virus in persons with haemophilia.
Angelotta C; McKoy JM; Fisher MJ; Buffie CG; Barfi K; Ramsey G; Frohlich L; Bennett CL
Vox Sang; 2007 Aug; 93(2):159-65. PubMed ID: 17683360
[TBL] [Abstract][Full Text] [Related]
40. Clinical spectrum of viral infections in hemophilic patients.
Telfer MC
Hematol Oncol Clin North Am; 1992 Oct; 6(5):1047-56. PubMed ID: 1328142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
